Viemed Healthcare, Inc. · NASDAQ:VMD
Viemed Healthcare — Q3 2026 Earnings Presentation
10 slides from Viemed Healthcare's earnings presentation, Nov 4, 2026
Slide 1: Financial Supplement Third Quarter 2026
1 Financial Supplement Third Quarter 2026 November 4, 2026 NASDAQ: VMD Viemed Healthcare, Inc.
Slide 2: Disclaimers - Forward Looking Statements
Disclaimers Forward Looking Statements Certain statements contained in this Financial Supplement may constitute “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 or “forward-looking information” as such term is defined in applicable Canadian
Slide 3: Key Themes for Q3 2026
Key Themes for Q3 2026 3 Delivered record quarterly revenue of $80.7 million, up 12.2% year over year and 3.3% sequentially, alongside a substantial improvement in sequential profitability. With Lehan included in both the current and prior-year quarters for the first time, these results underscore t
Slide 4: Financial and Operational Highlights
Financial and Operational Highlights 4 (expressed in thousands of U.S. Dollars, except operational information). (1) Refer to “Adjusted EBITDA" in this presentation for the definition of Adjusted EBITDA and a reconciliation to its most comparable GAAP measure. (2) Vent Patients represents the number
Slide 5: Service, Payor and Revenue Mix
Ventilation 49% Oxygen 9% Sleep 21% Airway Clearance 6% Women’s Health 6% Staffing 8% Other 1% Q3 2025 Medicare 37% Medicaid/ MCO 8% Medicare Advantage 20% Commercial 23% Other 12% Medicare 34% Medicaid/ MCO 9% Medicare Advantage 21% Commercial 24% Other 12% Ventilation 46% Oxygen 7% Sleep 23% Airwa
Slide 6: Revenue Highlights
Revenue Highlights 6 For the quarter ended 9/30/26 6/30/26 3/31/26 12/31/25 9/30/25 6/30/25 3/31/25 12/31/24 Rental Revenue (expressed in thousands of USD): Ventilators, non-invasive & invasive $37,460 $36,411 $35,360 $35,888 $34,883 $33,819 $32,159 $33,173 Other home medical equipment rentals $17,4
Slide 7: Liquidity Metrics
Liquidity Metrics 7 Positioned for growth • The Company maintains a healthy balance sheet with no net debt as of September 30, 2026, providing significant financial flexibility. • As of September 30, 2026, the Company had $46 million available under its existing credit facilities, supporting our cap
Slide 8: Free Cash Flow TTM
Free Cash Flow 8 TTM For the quarter ended 9/30/26 9/30/26 6/30/26 3/31/26 12/31/25 Net cash provided by operating activities $ 53,901 $ 11,487 $ 15,902 $ 8,071 $ 18,441 Less: Purchase of property and equipment (32,525) (8,616) (8,460) (6,712) (8,737) Proceeds from sale of property and equipment 4,6
Slide 9: 2026 Annual Guidance – Commentary
2026 Annual Guidance – Commentary 9 Core Metrics • Net revenue of $316 million to $320 million, raising the low end from $314 million. • Adjusted EBITDA of $64 million to $66 million, narrowed from $64 million to $68 million. • Net capital expenditures of 8.0% to 9.0% of net revenue, lowered from 8.
Slide 10: Adjusted EBITDA
Adjusted EBITDA 10 (a) Represents non-cash, equity-based compensation expense associated with option and RSU awards. (b) Represents transaction costs and expenses related to acquisition and integration efforts associated with recently announced or completed acquisitions. (c) Represents impairments o